Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-09-04, Stock:JNJ, The news for the past five days is as follows:
2020-08-28: NEWS1: Psychedelic Drugs Eye Long Trip To Legalization But This U.S. IPO Won't Wait.NEWS2: Johnson & Johnson stock rises Friday, still underperforms market.NEWS3: Hedge Funds Never Been This Bullish On Johnson & Johnson (JNJ).NEWS4: US STOCKS-Tech stocks power S&P 500 for seventh session in a row.NEWS5: Investors Are Betting Big on a Covid-19 Vaccine. Is That Safe?.NEWS6: US STOCKS-Tech stocks extend S&P 500's rally to seventh straight session.NEWS7: US STOCKS-Tech stocks extend S&P 500's rally to seventh straight session.NEWS8: US STOCKS-S&P 500 on pace for fifth straight record open.NEWS9: CORRECTED (OFFICIAL)-J&J's Janssen to begin Phase II COVID-19 vaccine trials next week in Spain.
2020-08-31: NEWS1: Catalent, IBD Stock Of The Day, Rides Covid Vaccine Deals To New Highs.NEWS2: Johnson & Johnson stock falls Monday, still outperforms market.NEWS3: The First Pure-Play Psychedelic Drugs IPO Reveals Clues On Emerging Industry.NEWS4: Coalition to Bill Barr: Imprison pharma executives for their roles in opioid crisis.NEWS5: Coronavirus update: FDA sparks new debate over 'following Russia, China' in vaccine push.NEWS6: Trudeau Unveils Covid-19 Vaccine Deals with Novavax, J&J.NEWS7: It’s Crunch Time for Vaccine News. Brace Yourself..NEWS8: REFILE-FOCUS-Scientists see downsides to top COVID-19 vaccines from Russia, China.
2020-09-01: NEWS1: Johnson & Johnson stock falls Tuesday, underperforms market.NEWS2: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.NEWS3: PRESS DIGEST-Canada - Sept 1.NEWS4: Forget Johnson & Johnson, AbbVie Is a Better Dividend Stock.
2020-09-02: NEWS1: Johnson & Johnson stock rises Wednesday, still underperforms market.NEWS2: Immunovant, Following Rival's Acquisition News, Prices Stock Offering.NEWS3: Johnson & Johnson Halts Development of Flu Treatment Candidate.NEWS4: A Look Into Johnson & Johnson's Price Over Earnings.NEWS5: ROCE Insights For Johnson & Johnson.NEWS6: J&J halts studies for experimental influenza A treatment.NEWS7: Sadly, One Letter Perfectly Captures the Recovery.
2020-09-03: NEWS1: Johnson & Johnson stock outperforms market despite losses on the day.NEWS2: 'Great for the manufacturers': How the law shields drug makers chasing a COVID vaccine.NEWS3: J&J's coronavirus vaccine candidate prevents severe disease in hamsters.NEWS4: We're still far away from a COVID-19 vaccine coming to market: Doctor.NEWS5: J&J to Stop Development of Influenza Candidate Pimodivir.NEWS6: EU hopeful first vaccine doses will come by end of year.NEWS7: Robinhood's &quot;Free Stock&quot; Offer Isn't All It's Cracked Up to Be.NEWS8: Better Coronavirus Stock: AstraZeneca or Johnson & Johnson?.

Answer: Decrease